Ascendis Pharma is a biopharmaceutical company that develops therapeutics for unmet medical needs. Its products include SKYTROFA for growth hormone deficiency, TransCon Growth Hormone for pediatric and adult GHD, TransCon parathyroid hormone for hypoparathyroidism, and TransCon CNP for achondroplasia. The company also develops TransCon toll like receptors 7/8 agonist and TransCon IL-2 ß/g. It was founded in 2006 and is based in Denmark.